ZUMA-7 (R/R)

ZUMA-7 (R/R)

A Phase 3, Randomized, Open-Label Study Evaluating Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link